
By Anne Wagstaff
More than 2 months after the October 1, 2011, deadline, the Centers for Medicare and Medicaid Services (CMS) has finally released the proposed rule that would implement the "Transparency Reports and Reporting of Physician Ownership or Investment Interests" section of the Patient Protection and Affordable Care Act (often referred to as the "Sunshine Act").
The proposed rule would require manufacturers of drugs, devices, biologicals, and medical supplies covered by Medicare, Medicaid, or the Children’s Health Insurance Program to report payments or other transfers of value made to physicians and teaching hospitals. It would also require manufacturers and group purchasing organizations (GPOs) to disclose physician ownership or investment interests.
Although the proposed rule is not scheduled to be published in the Federal Register until Monday, CMS issued a notice of proposed rulemaking yesterday and actually made available the unpublished rule.
So, what are the implications on timing for data collection and reporting?